Edward M Uchio

picture of Edward M Uchio

Professor of Clinical Urology, Urology
School of Medicine

Jerry D. Choate Endowed Chair in Urologic Oncology, Urology
School of Medicine

Director of Urologic Oncology, Urology
School of Medicine

Director of Clinical Trial Research, Urology
School of Medicine

Chair, Genito-urinary Disease Oriented Team (DOT), Urology
School of Medicine


B.S., University of California, Irvine, 1991
M.D., University of California, Irvine School of Medicine, 1995

Phone: (714) 456-6717
Fax: (888) 378-4358
Email: euchio@hs.uci.edu

University of California, Irvine
333 City Blvd West
Suite 2100
Mail Code: 5395
Orange, CA 92868
Short Biography
Urologic Oncology (fellowship trained)
Laparoscopic Surgery (fellowship trained) Robotic Surgery (Certified)
Minimally Invasive Surgery (Percutaneous/laparoscopic cryotherapy/RFA) High Intensity Focused Ultrasound (HIFU)/Focal Therapy (Certified)
MRI Fusion Biopsy
Clinical Trial Principal Investigator (CPI), Certified Physician Investigator
Grants
Agency: NIH I.D.#: 1 R01 CA237127-01 Title: Targeting mutant HRAS driven urothelial tumorigenesis by salidroside P.I.: Xiaolin Zi (PI) Role: Co-investigator Project Period: 04/01/2019-03/31/2024
Agency: California Initiative to Advance Precision Medicine (CIAPM) Title: The Integration of Genetic, Clinical Severity, and Patient Reported Complexity Variables to Predict Treatment Response and Disease Progression in a diverse population with Early Prostate Cancer P.I.: Edward M. Uchio, M.D., Sheldon Greenfield, M.D., Sherry Kaplan, PhD Project period: 12/1/2018 – 12/1/2020
Agency: California Initiative to Advance Precision Medicine (CIAPM) Title: Precision Medicine for Early Prostate Cancer: Integrating disease biomarkers and patient complexity indicators to predict treatment response P.I.: Edward M. Uchio, M.D., Sheldon Greenfield, M.D., Sherry Kaplan, PhD Project period: 12/1/2017 – 12/1/2018 (Supplement Grant)
Agency: California Initiative to Advance Precision Medicine (CIAPM) Title: Precision Medicine for Early Prostate Cancer: Integrating disease biomarkers and patient complexity indicators to predict treatment response P.I.: Edward M. Uchio, M.D., Sheldon Greenfield, M.D., Sherry Kaplan, PhD Project period: 12/1/2016 – 12/1/2018
Agency: Merck I.D.#: MISP-RC Title: Phase-I trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinoma P.I.: Jaime Landman, M.D. / Xiaolin Zi, Ph.D. Role: Co-investigator Project period: 10/1/2015 – 9/30/2018
Agency: NIH I.D.#: SBIR Grant Title: “Dedicated prostate MRI for urology.” P.I.: Edward M. Uchio, M.D. Percent effort: 15% Project period: Submitted
Agency: NIH I.D.#: SBIR Grant Title: “Dedicated prostate MRI for urology.” P.I.: Edward M. Uchio, M.D. Percent effort: 15% Project period: Submitted
Agency: NIH/NCI I.D.#: 1R21CA191389-01A1 Title: “U-CAT: Urethral Catheter Based Fluorescence Imaging Platform for Prostate Cancer.” P.I.: Gultekin Gulsen, Ph.D. Role: Co-investigator Project period: Submitted
Agency: NIH/NCI I.D.#: EDRN Grant Title: “Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse.” P.I.: Dan Mercola, Ph.D. Role: Site PI Project period: Submitted
Professional Societies
Program Evaluation Committee (PEC)
Orange County Urological Society
Ablation Oncology Center
Fellow of the American College of Surgeons
Society of Urologic Oncology
American Board of Urology
Association for Academic Surgery
Society of Laparoendoscopic Surgeons
Connecticut Chapter of the American College of Surgeons
Cancer Committee VA Connecticut Healthcare System
Yale University Cancer Center
Yale Society of Urologic Surgeons
New England Section, American Urologic Association
American Urological Association
Last updated
10/07/2020